Non-Keratinizing Nasopharyngeal Carcinoma with Adenomatous Differentiation

被引:0
|
作者
Fredrik Petersson
机构
[1] National University Health System,Department of Pathology
来源
Head and Neck Pathology | 2020年 / 14卷
关键词
Nasopharynx; Carcinoma; Adenocarcinoma; Epstein–Barr virus;
D O I
暂无
中图分类号
学科分类号
摘要
A case of non-keratinizing, EBV-positive (EBER-in situ hybridization), carcinoma with adenomatous differentiation is presented. The patient is a 40 year old male with T2N2M0 disease who received standard combined chemo- and radiotherapy with complete resolution of all tumor. The tumor cells were strongly positive for low-molecular weight cytokeratins (AE1–3) and scattered cells expressed cytokeratin 20. No expression of cytokeratin 5/6, 7, p63, TTF-1, CDX2 or androgen receptor was detected. There was no evidence of recurrence or disease progression on follow-up after 19 months, which included post treatment MRI and PET–CT scans.
引用
收藏
页码:195 / 198
页数:3
相关论文
共 50 条
  • [1] Non-Keratinizing Nasopharyngeal Carcinoma with Adenomatous Differentiation
    Petersson, Fredrik
    HEAD & NECK PATHOLOGY, 2020, 14 (01): : 195 - 198
  • [2] Non-keratinizing undifferentiated carcinoma of the nasopharynx
    Boia, E. R.
    Boia, Marioara
    Balica, N. C.
    Rusu, Laura-Cristina
    Mazilu, O.
    Solovan, C.
    Baderca, Flavia
    ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2013, 54 (03): : 839 - 843
  • [3] Preclinical activity of gefitinib in non-keratinizing nasopharyngeal carcinoma cell lines and biomarkers of response
    Brigette B.Y. Ma
    Vivian W.Y. Lui
    Fan Fong Poon
    S.C. Cesar Wong
    Ka Fai To
    Elaine Wong
    Honglin Chen
    Kwok Wai Lo
    Qian Tao
    Anthony T.C. Chan
    Investigational New Drugs, 2010, 28 : 326 - 333
  • [4] Reticular and Myxoid Non-keratinizing Nasopharyngeal Carcinoma: An Unusual Case Mimicking a Salivary Gland Carcinoma
    Petersson F.
    Vijayadwaja D.
    Loh K.S.
    Tan K.-B.
    Head and Neck Pathology, 2014, 8 (3) : 364 - 368
  • [5] Preclinical activity of gefitinib in non-keratinizing nasopharyngeal carcinoma cell lines and biomarkers of response
    Ma, Brigette B. Y.
    Lui, Vivian W. Y.
    Poon, Fan Fong
    Wong, S. C. Cesar
    To, Ka Fai
    Wong, Elaine
    Chen, Honglin
    Lo, Kwok Wai
    Tao, Qian
    Chan, Anthony T. C.
    INVESTIGATIONAL NEW DRUGS, 2010, 28 (03) : 326 - 333
  • [6] Preclinical evaluation of ribociclib and its synergistic effect in combination with alpelisib in non-keratinizing nasopharyngeal carcinoma
    Chi-Hang Wong
    Brigette B. Y. Ma
    Connie W. C. Hui
    Kwok-Wai Lo
    Edwin P. Hui
    Anthony T. C. Chan
    Scientific Reports, 8
  • [7] THROMBOMODULIN EXPRESSION IN KERATINIZING AND NON-KERATINIZING STRATIFIED SQUAMOUS EPITHELIUM CORRELATES WITH DIFFERENTIATION
    LAGER, DJ
    RAIFE, TJ
    LENTZ, SR
    LABORATORY INVESTIGATION, 1994, 70 (01) : A142 - A142
  • [8] Erratum to: Preclinical activity of gefitinib in non-keratinizing nasopharyngeal carcinoma cell lines and biomarkers of response
    Brigette B. Y. Ma
    Vivian W. Y. Lui
    Fan Fong Poon
    S. C. Cesar Wong
    Ka Fai To
    Elaine Wong
    Honglin Chen
    Kwok Wai Lo
    Qian Tao
    Margaret Heung Ling Ng
    Suk Hang Cheng
    Anthony T. C. Chan
    Investigational New Drugs, 2010, 28 (3) : 361 - 361
  • [9] Preclinical evaluation of ribociclib and its synergistic effect in combination with alpelisib in non-keratinizing nasopharyngeal carcinoma
    Wong, Chi-Hang
    Ma, Brigette B. Y.
    Hui, Connie W. C.
    Lo, Kwok-Wai
    Hui, Edwin P.
    Chan, Anthony T. C.
    SCIENTIFIC REPORTS, 2018, 8
  • [10] Expression of potential therapeutic target SSTR2a in primary and metastatic non-keratinizing nasopharyngeal carcinoma
    Tao, Lili
    Chen, Yaoli
    Shi, Xiaoxin
    Yu, Guangyin
    Yin, Weihua
    Huang, Yuhua
    VIRCHOWS ARCHIV, 2020, 477 (04) : 573 - 579